Optieum Biotechnologies
Optieum Biotechnologies is a biotech company in Toon, Japan, founded in 2020. It has raised $12.6M across 2 rounds, most recently a $10.0M Series A in January 2025.
Revolutionizing Immunity – Optimizing CAR-T for Breakthrough Therapies
- Headquarters
- Toon
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- optieumbio.com
- Total Funding
- $12.6M
- Last Round
- $10.0M Series AJan 2025
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 6 investors for this company. The full record is or through the API.
About
Optieum Biotechnologies Inc. is a clinical-stage biotechnology company developing next-generation CAR-T cell therapies for solid tumors and hematological malignancies. The company's core platform, the Eumbody System, uses empirical methodologies to identify optimized CAR constructs by dynamically harmonizing scFv sequences, enhancing T-cell functional capabilities including proliferative capacity, antigen escape prevention, and tumor reactivity. Optieum's lead program targets FAPa (cancer-associated fibroblasts in solid tumors) with additional programs targeting CD19. Founded in 2020, the company secured a JPY 290 million seed round in 2021, a JPY 1.33 billion Series A in January 2025, and a grant of up to $39 million from Japan's AMED in March 2025. The company is associated with Ehime University and has CDMO partnerships with Genezen and Cellipont Bioservices.
Summary
It lists 1–10 employees. It has raised $12.6M in total across 2 rounds, most recently a $10.0M Series A round in Jan 2025. Investors include Saisei Ventures, ANRI and Keio Innovation Initiative.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2025
Sign up to see all 2 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/optieum-biotechnologies"><img src="https://indexed.vc/api/badge/company/optieum-biotechnologies" alt="Optieum Biotechnologies on Indexed.vc" width="260" height="76" /></a>